Drupal.behaviors.print = function(context) {window.print();window.close();}>

MolecularMD Licenses LKB1 Marker for Lung Cancer Assay Development

January 28, 2013

MolecularMD Licenses LKB1 Marker for Lung Cancer Assay Development

By a GenomeWeb staff reporter

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories

Matrix-Bio Licenses Metabolomic Biomarkers to Quest for Breast Cancer Test Development

April 11, 2013 / GenomeWeb Daily News
Pfizer and Collaborators Developing Next-Gen Sequencing Test for Crizotinib Resistance Mutations

March 27, 2013 / Pharmacogenomics Reporter
FDA Clears ASI Gene Scanner as PGx Tool for NSCLC

February 15, 2013 / GenomeWeb Daily News
MolecularMD Offering a Range of Targeted Sequencing Services on PGM and MiSeq

January 9, 2013 / Clinical Sequencing News
Qiagen Expands Companion Dx Portfolio with Three Licensing Deals; Exceeds 2012 QiaSymphony Placement Target

January 7, 2013 / GenomeWeb Daily News